186 related articles for article (PubMed ID: 36152073)
1. Functional expression of mitochondrial K
Bulk E; Todesca LM; Bachmann M; Szabo I; Rieke M; Schwab A
Pflugers Arch; 2022 Nov; 474(11):1147-1157. PubMed ID: 36152073
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo.
Bachmann M; Rossa A; Varanita T; Fioretti B; Biasutto L; Milenkovic S; Checchetto V; Peruzzo R; Ahmad SA; Patel SH; Lukowski R; Edwards MJ; Ceccarelli M; Gulbins E; Zoratti M; Mattarei A; Szabo I
Cell Death Dis; 2022 Dec; 13(12):1055. PubMed ID: 36539400
[TBL] [Abstract][Full Text] [Related]
3. K
Glaser F; Hundehege P; Bulk E; Todesca LM; Schimmelpfennig S; Nass E; Budde T; Meuth SG; Schwab A
Sci Rep; 2021 Sep; 11(1):18330. PubMed ID: 34526525
[TBL] [Abstract][Full Text] [Related]
4. Targeting K
Todesca LM; Gerke M; Bulk EE; Bachmann M; Rudersdorf A; Antonuzzo L; Pillozzi S; Düfer M; Szabo I; Schwab A
Cell Death Discov; 2024 Jan; 10(1):2. PubMed ID: 38177097
[TBL] [Abstract][Full Text] [Related]
5. Intermediate conductance Ca2+-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells.
De Marchi U; Sassi N; Fioretti B; Catacuzzeno L; Cereghetti GM; Szabò I; Zoratti M
Cell Calcium; 2009 May; 45(5):509-16. PubMed ID: 19406468
[TBL] [Abstract][Full Text] [Related]
6. K
Bulk E; Kramko N; Liashkovich I; Glaser F; Schillers H; Schnittler HJ; Oberleithner H; Schwab A
Oncotarget; 2017 Dec; 8(68):112268-112282. PubMed ID: 29348824
[TBL] [Abstract][Full Text] [Related]
7. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
8. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
9. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
10. KCa3.1 Channels and Glioblastoma: In Vitro Studies.
Klumpp L; Sezgin EC; Skardelly M; Eckert F; Huber SM
Curr Neuropharmacol; 2018; 16(5):627-635. PubMed ID: 28786347
[TBL] [Abstract][Full Text] [Related]
11. Co-staining of K
Brömmel K; Maskri S; Bulk E; Pethő Z; Rieke M; Budde T; Koch O; Schwab A; Wünsch B
ChemMedChem; 2020 Dec; 15(24):2462-2469. PubMed ID: 33043595
[TBL] [Abstract][Full Text] [Related]
12. Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane.
Duffy SM; Ashmole I; Smallwood DT; Leyland ML; Bradding P
Cell Commun Signal; 2015 Jul; 13():32. PubMed ID: 26177720
[TBL] [Abstract][Full Text] [Related]
13. Calcium-gated K
Tarasov MV; Bystrova MF; Kotova PD; Rogachevskaja OA; Sysoeva VY; Kolesnikov SS
Pflugers Arch; 2017 Feb; 469(2):349-362. PubMed ID: 28028617
[TBL] [Abstract][Full Text] [Related]
14. The role and mechanism of K
Ma XZ; Pang ZD; Wang JH; Song Z; Zhao LM; Du XJ; Deng XL
Exp Cell Res; 2018 Aug; 369(2):208-217. PubMed ID: 29792849
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of KCa3.1 by depolarisation and 2-aminoethoxydiphenyl borate (2-APB) during Ca²⁺ release activated Ca²⁺ (CRAC) entry in human erythroleukemia (HEL) cells: Implications for the interpretation of 2-APB inhibition of CRAC entry.
Littlechild R; Zaidman N; Khodaverdi D; Mason MJ
Cell Calcium; 2015 Feb; 57(2):76-88. PubMed ID: 25601026
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels.
Brown BM; Shim H; Christophersen P; Wulff H
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():219-240. PubMed ID: 31337271
[TBL] [Abstract][Full Text] [Related]
17. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
Roach KM; Wulff H; Feghali-Bostwick C; Amrani Y; Bradding P
Respir Res; 2014 Dec; 15(1):155. PubMed ID: 25476248
[TBL] [Abstract][Full Text] [Related]
18. K
Bukhari M; Deng H; Sipes D; Ruane-Foster M; Purdy K; Woodworth CD; Sur S; Samways DSK
J Biol Chem; 2021; 296():100084. PubMed ID: 33199365
[TBL] [Abstract][Full Text] [Related]
19. The Ca(2+)-activated K(+) channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes.
Nicolaou SA; Neumeier L; Peng Y; Devor DC; Conforti L
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1431-9. PubMed ID: 17151145
[TBL] [Abstract][Full Text] [Related]
20. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.
Henríquez C; Riquelme TT; Vera D; Julio-Kalajzić F; Ehrenfeld P; Melvin JE; Figueroa CD; Sarmiento J; Flores CA
Acta Physiol (Oxf); 2016 Jan; 216(1):132-45. PubMed ID: 26138196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
